| Year |
Citation |
Score |
| 2020 |
Rauch DA, Olson SL, Harding JC, Sundaramoorthi H, Kim Y, Zhou T, MacLeod AR, Challen G, Ratner L. Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma. Retrovirology. 17: 27. PMID 32859220 DOI: 10.1186/S12977-020-00535-Z |
0.318 |
|
| 2020 |
Benz R, Arn K, Andres M, Pabst T, Baumann M, Novak U, Hitz F, Hess U, Zenhaeusern R, Chalandon Y, Mey U, Blum S, Rauch D, O'Meara Stern A, Cantoni N, et al. Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood Advances. 4: 3699-3707. PMID 32777066 DOI: 10.1182/Bloodadvances.2020002160 |
0.337 |
|
| 2019 |
Rauch DA, Conlon KC, Janakiram M, Brammer JE, Harding JC, Ye BH, Zang X, Ren X, Olson S, Cheng X, Miljkovic MD, Sundaramoorthi H, Joseph A, Skidmore ZL, Griffith O, et al. . Blood. PMID 31467059 DOI: 10.1182/Blood.2019002038 |
0.312 |
|
| 2019 |
Zucca E, Rondeau S, Vanazzi A, Østenstad B, Mey UJM, Rauch D, Wahlin BE, Hitz F, Hernberg M, Johansson AS, de Nully Brown P, Hagberg H, Ferreri AJM, Lohri A, Novak U, et al. Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy. Blood. PMID 31101627 DOI: 10.1182/Blood-2018-10-879643 |
0.333 |
|
| 2018 |
Cherian MA, Olson S, Sundaramoorthi H, Cates K, Cheng X, Harding J, Martens A, Challen GA, Tyagi M, Ratner L, Rauch D. An activating mutation of interferon regulatory factor 4 (IRF4) in adult T cell leukemia. The Journal of Biological Chemistry. PMID 29540473 DOI: 10.1074/Jbc.Ra117.000164 |
0.322 |
|
| 2018 |
Benz RA, Arn K, Andres M, Pabst T, Novak U, Hitz F, Zenhäusern R, Chalandon Y, Mey U, Blum S, Rauch D, Nettekoven W, Cantoni N, Bargetzi M, O'Meara A, et al. Prospective Long-Term Follow-up after First-Line Subcutaneous Cladribine Treatment in Patients with Hairy Cell Leukemia. a Study of the SAKK (Swiss Group for Clinical Cancer Research) Blood. 132: 2875-2875. DOI: 10.1182/Blood-2018-99-114301 |
0.339 |
|
| 2017 |
Rothschild S, Amrein M, Riether C, Gautschi O, Schuster N, Li Q, Savic S, Schneider M, Biaggi C, Bubendorf L, Brutsche M, Zippelius A, Zander T, Betticher D, Früh M, ... ... Rauch D, et al. MA 15.11 CCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19/09) Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2017.09.592 |
0.318 |
|
| 2016 |
Peters S, Stahel RA, Dafni U, Aix SP, Massutí B, Gautschi O, Coate L, López Martín A, van Heemst R, Berghmans T, Meldgaard P, Cobo Dols M, Noguera JG, Curioni-Fontecedro A, Rauch D, et al. Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first line platinum-based doublet chemotherapy stratified by Veristrat good versus Veristrat poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28017787 DOI: 10.1016/J.Jtho.2016.12.017 |
0.353 |
|
| 2016 |
Gautschi O, Rothschild SI, Li Q, Matter-Walstra K, Zippelius A, Betticher DC, Früh M, Stahel RA, Cathomas R, Rauch D, Pless M, Peters S, Froesch P, Zander T, Schneider M, et al. Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial. Clinical Lung Cancer. PMID 27993482 DOI: 10.1016/J.Cllc.2016.11.007 |
0.329 |
|
| 2016 |
Rochlitz C, Bigler M, von Moos R, Bernhard J, Matter-Walstra K, Wicki A, Zaman K, Anchisi S, Küng M, Na KJ, Bärtschi D, Borner M, Rordorf T, Rauch D, Müller A, et al. SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial. Bmc Cancer. 16: 780. PMID 27724870 DOI: 10.1186/S12885-016-2823-Y |
0.326 |
|
| 2016 |
Ratner L, Rauch D, Abel H, Caruso B, Noy A, Barta SK, Parekh S, Ramos JC, Ambinder R, Phillips A, Harding J, Baydoun HH, Cheng X, Jacobson S. Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma. Blood Cancer Journal. 6: e408. PMID 27015285 DOI: 10.1038/Bcj.2016.21 |
0.305 |
|
| 2016 |
Kimby E, Rondeau S, Vanazzi A, Ostenstad B, Mey UJM, Rauch D, Wahlin BE, Hitz F, Hernberg M, Johansson A, Brown PdN, Hagberg H, Ferreri AJM, Lohri A, Novak U, et al. Rituximab Plus Lenalidomide Versus Rituximab Monotherapy in Untreated Follicular Lymphoma Patients in Need of Therapy. First Analysis of Survival Endpoints of the Randomized Phase-2 Trial SAKK 35/10 Blood. 128: 1099-1099. DOI: 10.1182/Blood.V128.22.1099.1099 |
0.324 |
|
| 2015 |
Taverna C, Martinelli G, Hitz F, Mingrone W, Pabst T, Cevreska L, Del Giglio A, Vanazzi A, Laszlo D, Raats J, Rauch D, Vorobiof DA, Lohri A, Biaggi Rudolf C, Rondeau S, et al. Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26712227 DOI: 10.1200/Jco.2015.61.3968 |
0.328 |
|
| 2015 |
Mueller BU, Keller S, Seipel K, Mansouri Taleghani B, Rauch D, Betticher D, Egger T, Pabst T. Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity. Leukemia & Lymphoma. 1-8. PMID 26294015 DOI: 10.3109/10428194.2015.1079315 |
0.31 |
|
| 2015 |
Pless M, Stupp R, Ris HB, Stahel RA, Weder W, Thierstein S, Gerard MA, Xyrafas A, Früh M, Cathomas R, Zippelius A, Roth A, Bijelovic M, Ochsenbein A, Meier UR, ... ... Rauch D, et al. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet (London, England). 386: 1049-56. PMID 26275735 DOI: 10.1016/S0140-6736(15)60294-X |
0.338 |
|
| 2015 |
Gautschi O, Mach N, Rothschild SI, Li Q, Stahel RA, Zippelius A, Cathomas R, Früh M, Betticher DC, Peters S, Rauch D, Feilchenfeldt J, Bubendorf L, Savic S, Jaggi R, et al. Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical Lung Cancer. PMID 25843489 DOI: 10.1016/J.Cllc.2015.02.007 |
0.343 |
|
| 2015 |
Helbling D, Bodoky G, Gautschi O, Hayoz S, Bosman F, Madlung A, Gloor B, Burkhard R, Rauch D, Winterhalder RC, Saletti P, Widmer L, Borner MM, Baertschi D, Yan P, et al. Neoadjuvant chemoradiation (CRT) with or without panitumumab (Pan) in patients with K-ras unmutated, locally advanced rectal cancer (LARC): Final results of a randomized multicenter phase II trial (SAKK 41/07). Journal of Clinical Oncology. 33: 762-762. DOI: 10.1200/Jco.2015.33.3_Suppl.762 |
0.324 |
|
| 2015 |
Ratner L, Ramos J, Noy A, Barta S, Parikh S, Phillips A, Ambinder R, Rauch D, Harding J, Baydoun H, Cheng X, Caruso B, Jacobson S. Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma Retrovirology. 12. DOI: 10.1186/1742-4690-12-S1-P21 |
0.34 |
|
| 2015 |
Cathomas R, Crabb S, Kenner H, Mark M, Rothermundt C, Elliott T, Winterhalder R, Burg PV, Vilei SB, Hayoz S, Rauch D, Roggero E, Stenner F, Berthold D, Erdmann A, et al. 2500 Orteronel (Ort) maintenance therapy in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) and non-progressive disease after first-line docetaxel (Doc) therapy: Results of a multicenter randomized double-blind placebo-controlled phase III trial (SAKK 08/11) European Journal of Cancer. 51. DOI: 10.1016/S0959-8049(15)30045-9 |
0.305 |
|
| 2014 |
Rochlitz C, Moos Rv, Bigler M, Zaman K, Anchisi S, Küng M, Na KJ, Baertschi D, Borner MM, Rordorf T, Rauch D, Mueller A, Ruhstaller T, Vetter M, Bernhard J, et al. SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel versus bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer—A multicenter, randomized phase III trial. Journal of Clinical Oncology. 32: 518-518. DOI: 10.1200/Jco.2014.32.15_Suppl.518 |
0.333 |
|
| 2014 |
Kimby E, Martinelli G, Ostenstad B, Mey UJM, Rauch D, Wahlin BE, Hitz F, Hernberg M, Johansson A, Brown PdN, Hagberg H, Ferreri AJM, Lohri A, Novak U, Zander T, et al. Rituximab Plus Lenalidomide Improves the Complete Remission Rate in Comparison with Rituximab Monotherapy in Untreated Follicular Lymphoma Patients in Need of Therapy. Primary Endpoint Analysis of the Randomized Phase-2 Trial SAKK 35/10 Blood. 124: 799-799. DOI: 10.1182/Blood.V124.21.799.799 |
0.303 |
|
| 2013 |
Helbling D, Bodoky G, Gautschi O, Sun H, Bosman F, Gloor B, Burkhard R, Winterhalder R, Madlung A, Rauch D, Saletti P, Widmer L, Borner M, Baertschi D, Yan P, et al. Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 718-25. PMID 23139259 DOI: 10.1093/Annonc/Mds519 |
0.305 |
|
| 2013 |
Früh M, Cathomas R, Siano M, Tscherry G, Zippelius A, Mamot C, Erdmann A, Krasniqi F, Rauch D, Simcock M, Küttel E, Fustier P, Pless M. Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08). Clinical Lung Cancer. 14: 34-9. PMID 22633220 DOI: 10.1016/J.Cllc.2012.04.001 |
0.349 |
|
| 2013 |
Pless M, Stupp R, Ris H, Stahel RA, Weder W, Thierstein S, Xyrafas A, Frueh M, Cathomas R, Zippelius A, Roth A, Bijelovic M, Ochsenbein A, Meier UR, Mamot C, ... Rauch D, et al. Neoadjuvant chemotherapy with or without preoperative irradiation in stage IIIA/N2 non-small cell lung cancer (NSCLC): A randomized phase III trial by the Swiss Group for Clinical Cancer Research (SAKK trial 16/00). Journal of Clinical Oncology. 31: 7503-7503. DOI: 10.1200/Jco.2013.31.15_Suppl.7503 |
0.32 |
|
| 2012 |
Zappa F, Droege C, Betticher D, von Moos R, Bubendorf L, Ochsenbein A, Gautschi O, Oppliger Leibundgut E, Froesch P, Stahel R, Hess T, Rauch D, Schmid P, Mayer M, Crowe S, et al. Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05). Lung Cancer (Amsterdam, Netherlands). 78: 239-44. PMID 23009726 DOI: 10.1016/J.Lungcan.2012.08.017 |
0.322 |
|
| 2011 |
Rauch DA, Ratner L. Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients. Viruses. 3: 886-900. PMID 21994759 DOI: 10.3390/V3060886 |
0.334 |
|
| 2008 |
D'Addario G, Rauch D, Stupp R, Pless M, Stahel R, Mach N, Jost L, Widmer L, Tapia C, Bihl M, Mayer M, Ribi K, Lerch S, Bubendorf L, Betticher DC. Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 19: 739-45. PMID 18096565 DOI: 10.1093/Annonc/Mdm564 |
0.355 |
|
| 2007 |
Hess D, Koberle D, Thurlimann B, Pagani O, Schonenberger A, Mattmann S, Rochlitz C, Rauch D, Schuller JC, Ballabeni P, Ribi K. Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99). Oncology. 73: 228-37. PMID 18424887 DOI: 10.1159/000127414 |
0.323 |
|
| 2006 |
Salzberg M, Borner M, Bauer JA, Morant R, Rauch D, Rochlitz C. Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients. European Journal of Cancer (Oxford, England : 1990). 42: 2660-1. PMID 16934972 DOI: 10.1016/J.Ejca.2006.06.009 |
0.355 |
|
| 2006 |
D'Addario G, Strasser F, Ribi K, Rauch D, Stupp R, Pless M, Stahel RA, Rufibach K, Lerch S, Betticher D. Quality of life (QoL) in SAKK 19/03: A multicenter phase II study of first-line gefitinib followed by chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). Swiss Group for Clinical Cancer Research (SAKK) Journal of Clinical Oncology. 24: 18559-18559. DOI: 10.1200/Jco.2006.24.18_Suppl.18559 |
0.325 |
|
| 2005 |
Borner MM, Bernhard J, Dietrich D, Popescu R, Wernli M, Saletti P, Rauch D, Herrmann R, Koeberle D, Honegger H, Brauchli P, Lanz D, Roth AD. A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 16: 282-8. PMID 15668285 DOI: 10.1093/Annonc/Mdi047 |
0.316 |
|
| 2005 |
D'Addario G, Rauch D, Stupp R, Stahel R, Pless M, Mach N, Rufibach K, Petersen J, Betticher DC. Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small cell lung cancer (NSCLC): Preliminary results. A study of the Swiss Group for Clinical Cancer Research (SAKK) Journal of Clinical Oncology. 23: 7128-7128. DOI: 10.1200/Jco.2005.23.16_Suppl.7128 |
0.326 |
|
| 2004 |
Borner MM, Bernhard J, Dietrich D, Popescu R, Wernli M, Saletti P, Rauch D, Herrmann R, Roth A. The impact of the irinotecan (IRI) schedule on quality of life in combination with capecitabine (CAP) in first-line treatment of metastatic colorectal cancer (MCC): A randomized phase II trial of the Swiss Group for Clinical Cancer Research. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 8120. PMID 28015335 DOI: 10.1200/Jco.2004.22.14_Suppl.8120 |
0.313 |
|
| 2004 |
Uhlmann C, Ballabeni P, Rijken N, Brauchli P, Mingrone W, Rauch D, Pestalozzi BC, Rochlitz C, Aebi S. Capecitabine with weekly paclitaxel for advanced breast cancer: a phase I dose-finding trial. Oncology. 67: 117-122. PMID 15539915 DOI: 10.1159/000080997 |
0.301 |
|
| 2001 |
Huber MT, Wisner TW, Hegde NR, Goldsmith KA, Rauch DA, Roller RJ, Krummenacher C, Eisenberg RJ, Cohen GH, Johnson DC. Herpes simplex virus with highly reduced gD levels can efficiently enter and spread between human keratinocytes. Journal of Virology. 75: 10309-18. PMID 11581399 DOI: 10.1128/Jvi.75.21.10309-10318.2001 |
0.619 |
|
| 2000 |
Rauch DA, Rodriguez N, Roller RJ. Mutations in herpes simplex virus glycoprotein D distinguish entry of free virus from cell-cell spread. Journal of Virology. 74: 11437-46. PMID 11090139 DOI: 10.1128/Jvi.74.24.11437-11446.2000 |
0.624 |
|
| 1998 |
Roller RJ, Rauch D. Herpesvirus entry mediator HVEM mediates cell-cell spread in BHK(TK-) cell clones Journal of Virology. 72: 1411-1417. PMID 9445042 DOI: 10.1128/Jvi.72.2.1411-1417.1998 |
0.626 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2011 |
Ruhstaller T, Pless M, Dietrich D, Kranzbuehler H, von Moos R, Moosmann P, Montemurro M, Schneider PM, Rauch D, Gautschi O, Mingrone W, Widmer L, Inauen R, Brauchli P, Hess V. Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 626-31. PMID 21205757 DOI: 10.1200/Jco.2010.31.9715 |
0.3 |
|
| 2016 |
Gilli S, Novak U, Taleghani BM, Baerlocher GM, Leibundgut K, Banz Y, Zander T, Betticher D, Egger T, Rauch D, Pabst T. BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients. Annals of Hematology. PMID 28011985 DOI: 10.1007/S00277-016-2900-Y |
0.299 |
|
| 2009 |
Rauch D, Gross S, Harding J, Bokhari S, Niewiesk S, Lairmore M, Piwnica-Worms D, Ratner L. T-cell activation promotes tumorigenesis in inflammation-associated cancer. Retrovirology. 6: 116. PMID 20017942 DOI: 10.1186/1742-4690-6-116 |
0.299 |
|
| 2004 |
Hess D, Thürlimann B, Pagani O, Aebi S, Rauch D, Ballabeni P, Rufener B, Castiglione-Gertsch M, Goldhirsch A. Capecitabine and vinorelbine in elderly patients (≥65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99) Annals of Oncology. 15: 1760-1765. PMID 15550580 DOI: 10.1093/Annonc/Mdh467 |
0.297 |
|
| 2017 |
Rosell R, Dafni U, Felip E, Curioni-Fontecedro A, Gautschi O, Peters S, Massutí B, Palmero R, Aix SP, Carcereny E, Früh M, Pless M, Popat S, Kotsakis A, Cuffe S, ... ... Rauch D, et al. Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. The Lancet. Respiratory Medicine. PMID 28408243 DOI: 10.1016/S2213-2600(17)30129-7 |
0.296 |
|
| 2016 |
Cinieri S, Chan A, Altundag K, Vandebroek A, Tubiana-Mathieu N, Barnadas A, Dodyk P, Lazzarelli S, Botha M, Rauch D, Villanova G, Coskun U. Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer. Clinical Breast Cancer. PMID 27756583 DOI: 10.1016/J.Clbc.2016.06.014 |
0.294 |
|
| 2017 |
Rothschild S, Gautschi O, Schuster N, Li Q, Savic S, Schneider M, Biaggi C, Bubendorf L, Brutsche M, Zippelius A, Zander T, Betticher D, Früh M, Stahel R, Cathomas R, ... Rauch D, et al. PUB041 HGF, VEGFA and ANGPT2 Predict Clinical Benefit from Bevacizumab and Chemotherapy in Patients with Advanced NSCLC (SAKK19/09) Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2016.11.2011 |
0.294 |
|
| 2014 |
Cinieri S, Chan A, Altundag K, Vandebroek A, Tubiana-Mathieu N, Barnadas A, Dodyk P, Lazzarelli S, Botha M, Rauch D, Khasanov R, Slabber CF, Bougnoux P, Cardenas JS, Diez JC, et al. Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial). Journal of Clinical Oncology. 32: 1044-1044. DOI: 10.1200/Jco.2014.32.15_Suppl.1044 |
0.292 |
|
| 2017 |
von Moos R, Koeberle D, Schacher S, Hayoz S, Winterhalder RC, Roth A, Bodoky G, Samaras P, Berger MD, Rauch D, Saletti P, Plasswilm L, Zwahlen D, Meier UR, Yan P, et al. Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08). European Journal of Cancer (Oxford, England : 1990). 89: 82-89. PMID 29241084 DOI: 10.1016/J.Ejca.2017.11.005 |
0.292 |
|
| 2016 |
Esser A, Rauch D, Xiang J, Harding J, Kohart N, Green P, Niewiesk S, Rosol T, Ratner L, Weilbaecher K. Abstract 3285: HTLV-1 viral oncogene Hbz induces leukemia with osteolytic bone involvement in mice Cancer Research. 76: 3285-3285. DOI: 10.1158/1538-7445.Am2016-3285 |
0.292 |
|
| 2017 |
Esser AK, Rauch DA, Xiang J, Harding JC, Kohart NA, Ross MH, Su X, Wu K, Huey D, Xu Y, Vij K, Green PL, Rosol TJ, Niewiesk S, Ratner L, et al. HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice. Oncotarget. 8: 69250-69263. PMID 29050201 DOI: 10.18632/Oncotarget.20565 |
0.291 |
|
| 2014 |
Moos RV, Koeberle D, Schacher S, Hayoz S, Winterhalder RC, Roth A, Bodoky G, Samaras P, Berger MD, Rauch D, Saletti P, Plasswilm L, Thum P, Meier UR, Yan P, et al. Neoadjuvant radiotherapy (RT) combined with capecitabine (Cape) and sorafenib (Sor) in patients (pts) with locally advanced, k-ras-mutated rectal cancer (LARC): A phase I/II trial SAKK 41/08. Journal of Clinical Oncology. 32: 3531-3531. DOI: 10.1200/Jco.2014.32.15_Suppl.3531 |
0.288 |
|
| 2006 |
Ratner L, Bernal-Mizrachi L, Rauch D, Harding J, Gross S, Piwnica-Worms D. Bioluminescence Imaging of Spontaneous Lymphomas and Contribution of Distinct NFκB Pathways. Blood. 108: 2377-2377. DOI: 10.1182/Blood.V108.11.2377.2377 |
0.287 |
|
| 2009 |
Rauch D, Gross S, Harding J, Niewiesk S, Lairmore M, Piwnica-Worms D, Ratner L. Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. Blood. 113: 1493-500. PMID 18971418 DOI: 10.1182/Blood-2008-07-166462 |
0.284 |
|
| 2019 |
Xiang J, Rauch DA, Huey DD, Panfil AR, Cheng X, Esser AK, Su X, Harding JC, Xu Y, Fox GC, Fontana F, Kobayashi T, Su J, Sundaramoorthi H, Wong WH, et al. HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia. Jci Insight. 4. PMID 31578308 DOI: 10.1172/Jci.Insight.128713 |
0.284 |
|
| 2011 |
Rauch D, Bokhari S, Harding J, Ratner L. Tet-inducible lymphoma in a new Tax transgenic mouse model Retrovirology. 8: A4. DOI: 10.1186/1742-4690-8-S1-A4 |
0.281 |
|
| 2013 |
Baty F, Rothschild S, Früh M, Betticher D, Dröge C, Cathomas R, Rauch D, Gautschi O, Bubendorf L, Crowe S, Zappa F, Pless M, Brutsche M. EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer. Plos One. 8: e72966. PMID 24039832 DOI: 10.1371/Journal.Pone.0072966 |
0.28 |
|
| 2019 |
Menter T, Tzankov A, Zucca E, Kimby E, Vanazzi A, Østenstad B, Mey UJ, Rauch D, Wahlin B, Hitz F, Hernberg M, Johansson A, Brown PdN, Hagberg H, Hawle H, et al. Prognostic Implications Of The Microenvironment In Follicular Lymphoma Under Rituximab And Rituximab+Lenalidomide Therapy. A Translational Study Of The Sakk35/10 Trial Hematological Oncology. 37: 149-151. DOI: 10.1002/Hon.107_2629 |
0.277 |
|
| 2017 |
Stenner F, Rothschild SI, Betticher D, Caspar C, Morant R, Popescu R, Rauch D, Huber U, Zenhäusern R, Rentsch C, Cathomas R. Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment Registry. Clinical Genitourinary Cancer. PMID 28958629 DOI: 10.1016/J.Clgc.2017.08.003 |
0.277 |
|
| 2005 |
Rauch DA, Percelay JM, Zipes D. Introduction to pediatric hospital medicine. Pediatric Clinics of North America. 52: 963-77, vii. PMID 16009252 DOI: 10.1016/J.Pcl.2005.03.005 |
0.275 |
|
| 2010 |
Mittal VS, Sigrest T, Ottolini MC, Rauch D, Lin H, Kit B, Landrigan CP, Flores G. Family-centered rounds on pediatric wards: a PRIS network survey of US and Canadian hospitalists. Pediatrics. 126: 37-43. PMID 20587682 DOI: 10.1542/Peds.2009-2364 |
0.275 |
|
| 2012 |
Rauch DA, Lye PS, Carlson D, Daru JA, Narang S, Srivastava R, Melzer S, Conway PH. Pediatric hospital medicine: a strategic planning roundtable to chart the future. Journal of Hospital Medicine. 7: 329-34. PMID 21994159 DOI: 10.1002/Jhm.950 |
0.273 |
|
| 2016 |
Courchia B, Zaidi AH, Roberts KB, Rauch DA. Hospitalized UTI Demographics after 2011 AAP UTI Guidelines Pediatrics. 140: 34-34. DOI: 10.1542/Peds.140.1_Meetingabstract.34 |
0.273 |
|
| 2012 |
Maloney CG, Mendez SS, Quinonez RA, Bode RS, Brands CK, Eagle S, Osorio SN, Rauch D, Simon TD. The Strategic Planning Committee report: the first step in a journey to recognize pediatric hospital medicine as a distinct discipline. Hospital Pediatrics. 2: 187-90. PMID 24313023 DOI: 10.1542/Hpeds.2012-0048 |
0.271 |
|
| 2017 |
Pagani O, Bagnardi V, Ruggeri M, Bianco N, Gallerani E, Buser K, Giordano M, Gianni L, Rabaglio M, Freschi A, Cretella E, Clerico M, Amadori D, Simoncini E, Ciccarese M, ... Rauch D, et al. Abstract PD6-04: HOHO study: How European and US young women cope with breast cancer and fertility concerns Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-Pd6-04 |
0.27 |
|
| 2016 |
Gautschi O, Li Q, Matter-Walstra K, Betticher D, Frueh M, Rauch D, Pless M, Froesch P, Mach N, Ochsenbein A. 143PD: Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19/09 trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: S120. PMID 27198283 DOI: 10.1016/S1556-0864(16)30253-2 |
0.269 |
|
| 2013 |
Mirkinson LJ, Daru JA, Fisher ERS, Garber MD, Hain PD, Steve Narang A, Quinonez RA, Rauch DA, Aragona E, Niccole Alexander S. Guiding principles for pediatric hospital medicine programs Pediatrics. 132: 782-786. PMID 24081997 DOI: 10.1542/Peds.2013-2269 |
0.269 |
|
| 2016 |
Cathomas R, Crabb SJ, Mark M, Winterhalder R, Rothermundt C, Elliott T, von Burg P, Kenner H, Hayoz S, Vilei SB, Rauch D, Roggero E, Mohaupt MG, Bernhard J, Manetsch G, et al. Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11). The Prostate. PMID 27457964 DOI: 10.1002/Pros.23236 |
0.267 |
|
| 2018 |
Rauch DA. Physician's Role in Coordinating Care of Hospitalized Children. Pediatrics. 142. PMID 30061298 DOI: 10.1542/Peds.2018-1503 |
0.265 |
|
| 2006 |
Lye PS, Rauch DA, Ottolini MC, Landrigan CP, Chiang VW, Srivastava R, Muret-Wagstaff S, Ludwig S. Pediatric hospitalists: report of a leadership conference. Pediatrics. 117: 1122-30. PMID 16585306 DOI: 10.1542/Peds.2005-0401 |
0.263 |
|
| 2018 |
Khare M, Goudie A, Rauch DA. National Pediatric Bed Occupancy Pediatrics. 141: 420-420. DOI: 10.1542/Peds.141.1_Meetingabstract.420 |
0.261 |
|
| 2019 |
Rothschild SI, Betticher D, Zenhäusern R, Anchisi S, von Moos R, Pless M, Moosmann P, Popescu RA, Calderoni A, Dressler M, Rauch D, Pederiva S, Woelky R, Papet C, Bühler V, et al. Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study. Cancer Chemotherapy and Pharmacology. PMID 31444619 DOI: 10.1007/S00280-019-03927-X |
0.26 |
|
| 2016 |
Khare M, Rauch DA. Trends in National Pediatric Bed Census Pediatrics. 140: 20-20. DOI: 10.1542/Peds.140.1_Meetingabstract.20 |
0.259 |
|
| 2016 |
Aragona E, Rauch DA. Ongoing Trends in Pediatric Hospitalizations Pediatrics. 137: 33-33. DOI: 10.1542/Peds.140.1_Meetingabstract.33 |
0.257 |
|
| 2011 |
Choudhary G, Rauch D, Ratner L. The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30-II mRNA Retrovirology. 8: A136. DOI: 10.1186/1742-4690-8-S1-A136 |
0.257 |
|
| 2016 |
Colleoni M, Gray KP, Gelber S, Láng I, Thürlimann B, Gianni L, Abdi EA, Gomez HL, Linderholm BK, Puglisi F, Tondini C, Kralidis E, Eniu A, Cagossi K, Rauch D, et al. Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance For Hormone Receptor-Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27325862 DOI: 10.1200/Jco.2015.65.6595 |
0.256 |
|
| 2016 |
Ramirez DC, Courchia B, Roberts KB, Rauch DA. Changes in UTI Hospitalizations after the 2011 AAP UTI Guidelines Pediatrics. 140: 35-35. DOI: 10.1542/Peds.140.1_Meetingabstract.35 |
0.255 |
|
| 2012 |
Oshimura J, Sperring J, Bauer BD, Rauch DA. Inpatient staffing within pediatric residency programs: work hour restrictions and the evolving role of the pediatric hospitalist. Journal of Hospital Medicine. 7: 299-303. PMID 22038872 DOI: 10.1002/Jhm.952 |
0.255 |
|
| 2019 |
Ruggeri M, Pagan E, Bagnardi V, Bianco N, Gallerani E, Buser K, Giordano M, Gianni L, Rabaglio M, Freschi A, Cretella E, Clerico M, Farolfi A, Simoncini E, Ciccarese M, ... Rauch D, et al. Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers. Breast (Edinburgh, Scotland). 47: 85-92. PMID 31362134 DOI: 10.1016/J.Breast.2019.07.001 |
0.255 |
|
| 2012 |
Rauch DA. Medical staff appointment and delineation of pediatric privileges in hospitals. Pediatrics. 129: 784-7. PMID 22451705 DOI: 10.1542/Peds.2011-3866 |
0.255 |
|
| 2012 |
Daru JA, Holmes A, Starmer AJ, Aquino J, Rauch DA. Pediatric hospitalists' influences on education and career plans. Journal of Hospital Medicine. 7: 282-6. PMID 21997893 DOI: 10.1002/Jhm.962 |
0.255 |
|
| 2015 |
Singh A, Rauch D. Commercial Premixed Parenteral Nutrition and Its Potential Role in Pediatrics. Hospital Pediatrics. PMID 26644046 DOI: 10.1542/Hpeds.2015-0147 |
0.253 |
|
| 2010 |
Rauch DA, Hurchla MA, Harding JC, Deng H, Shea LK, Eagleton MC, Niewiesk S, Lairmore MD, Piwnica-Worms D, Rosol TJ, Weber JD, Ratner L, Weilbaecher KN. The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice. Plos One. 5: e15755. PMID 21209895 DOI: 10.1371/Journal.Pone.0015755 |
0.252 |
|
| 2004 |
Amin AN, Ansari A, Blatt MB, Borik A, Feinbloom D, Krekun S, Li J, Pak M, Rao S, Rauch DA. In-hospital initiation of lipid-lowering therapy: the role of the hospitalist. Critical Pathways in Cardiology. 3: S17-9. PMID 18340164 DOI: 10.1097/01.Hpc.0000137964.94779.D9 |
0.25 |
|
| 2013 |
Schwartz SB, Rauch D. Intravenous acetaminophen: an alternative to opioids for pain management? Hospital Pediatrics. 3: 294-6. PMID 24313101 DOI: 10.1542/Hpeds.2013-0014 |
0.248 |
|
| 2015 |
Pujari R, Hunte R, Thomas R, van der Weyden L, Rauch D, Ratner L, Nyborg JK, Ramos JC, Takai Y, Shembade N. Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling. Plos Pathogens. 11: e1004721. PMID 25774694 DOI: 10.1371/Journal.Ppat.1004721 |
0.247 |
|
| 2008 |
Paulose NS, Hart D, Rauch D. Neonatal Hyperbilirubinemia: An Unexpected Cause Clinical Pediatrics. 47: 388-394. PMID 18057144 DOI: 10.1177/0009922807310242 |
0.246 |
|
| 2000 |
Rauch DA. Hair relaxer misuse: Don't relax Pediatrics. 105: 1154-1155. PMID 10790479 DOI: 10.1542/Peds.105.5.1154 |
0.246 |
|
| 2004 |
Amin AN, Borik A, Debellis RJ, Feinbloom D, Krekun S, Li J, Pak M, Rauch D, Schwartz DB. Community- and hospital-acquired pneumonia-the role of the hospitalist in improving outcomes and reducing resource utilization. Current Opinion in Pulmonary Medicine. 10: S1-2. PMID 15514485 DOI: 10.1097/01.Mcp.0000143177.38376.84 |
0.244 |
|
| 2011 |
Rauch D, Bokhari S, Harding J, Ratner L. The effects of XMRV gene expression on the mouse prostate Retrovirology. 8: A223. DOI: 10.1186/1742-4690-8-S1-A223 |
0.243 |
|
| 2004 |
Amin AN, Feinbloom D, Krekun S, Li J, Pak M, Rauch DA, Borik A. Recommendations for management of community- and hospital-acquired pneumonia-the hospitalist perspective. Current Opinion in Pulmonary Medicine. 10: S23-7. PMID 15514488 DOI: 10.1097/01.Mcp.0000143181.68870.E6 |
0.242 |
|
| 2007 |
Percelay JM, Rauch DA, Zipes D. Chapter 23 – Pediatric Hospital Medicine Organizations Comprehensive Pediatric Hospital Medicine. 109-112. DOI: 10.1016/B978-032303004-5.50027-2 |
0.241 |
|
| 2017 |
Chung EK, Gable EK, Golden WC, Hudson JA, Hackman NM, Andrews JP, Jackson DS, Beavers JB, Mirchandani DR, Kellams A, Krevitsky ME, Monroe K, Madlon-Kay DJ, Stratbucker W, Campbell D, ... ... Rauch D, et al. Current Scope of Practice for Newborn Care in Non-Intensive Hospital Settings. Hospital Pediatrics. PMID 28694290 DOI: 10.1542/Hpeds.2016-0206 |
0.241 |
|
| 2005 |
Wielgosz MM, Rauch DA, Jones KS, Ruscetti FW, Ratner L. Cholesterol dependence of HTLV-I infection. Aids Research and Human Retroviruses. 21: 43-50. PMID 15665643 DOI: 10.1089/Aid.2005.21.43 |
0.241 |
|
| 2014 |
Koeberle D, Dufour J, Demeter G, Samaras P, Saletti P, Li Q, Roth A, Horber D, Buehlmann M, Wagner AD, Montemurro M, Lakatos G, Ribi K, Feilchenfeld J, Peck-Radosavljevic M, ... Rauch D, et al. Sorafenib with or without everolimus in patients with unresectable hepatocellular carcinoma (HCC): A randomized multicenter phase II trial (SAKK 77/08 and SASL 29). Journal of Clinical Oncology. 32: 4099-4099. DOI: 10.1200/Jco.2014.32.15_Suppl.4099 |
0.239 |
|
| 2005 |
Samuels RC, Chi GW, Rauch DA, Palfrey JS, Shelov SP. Lessons from pediatrics residency program directors' experiences with work hour limitations in New York State. Academic Medicine : Journal of the Association of American Medical Colleges. 80: 467-72. PMID 15851460 DOI: 10.1097/00001888-200505000-00013 |
0.237 |
|
| 2014 |
Oshimura JM, Sperring J, Bauer BD, Carroll AE, Rauch DA. Changes in inpatient staffing following implementation of new residency work hours. Journal of Hospital Medicine. 9: 640-5. PMID 25078706 DOI: 10.1002/Jhm.2242 |
0.237 |
|
| 2009 |
Gross S, Gammon ST, Moss BL, Rauch D, Harding J, Heinecke JW, Ratner L, Piwnica-Worms D. Bioluminescence imaging of myeloperoxidase activity in vivo. Nature Medicine. 15: 455-61. PMID 19305414 DOI: 10.1038/Nm.1886 |
0.234 |
|
| 1998 |
Rauch DA. Use of ketamine in a pain management protocol for repetitive procedures Pediatrics. 102: 404-405. PMID 9714653 DOI: 10.1542/Peds.102.2.404 |
0.23 |
|
| 2014 |
Rauch DA, Harding JC, Ratner L. IL-15 deficient tax mice reveal a role for IL-1α in tumor immunity. Plos One. 9: e85028. PMID 24416335 DOI: 10.1371/Journal.Pone.0085028 |
0.227 |
|
| 2011 |
Rauch D, Bokhari S, Harding J, Ratner L. IL-15 deficiency promotes tumor growth in tax transgenic mice Retrovirology. 8: A24. DOI: 10.1186/1742-4690-8-S1-A24 |
0.224 |
|
| 2012 |
Sasaki J, Parajuli N, Sharma P, Nanda M, Shah R, Gershel J, Rauch DA. Utility of post-urinary tract infection imaging in patients with normal prenatal renal ultrasound. Clinical Pediatrics. 51: 244-6. PMID 21890838 DOI: 10.1177/0009922811420712 |
0.224 |
|
| 2015 |
Rauch DA, Quinonez RA. Counting Hospitalists--Does it Matter? Hospital Pediatrics. 5: 232-3. PMID 25832978 DOI: 10.1542/Hpeds.2015-0043 |
0.223 |
|
| 1999 |
Rauch DA, Ewig J, Benoit PE, Clark E, Bijur P. Exploring intermittent transcutaneous CO2 monitoring Critical Care Medicine. 27: 2358-2360. PMID 10579248 DOI: 10.1097/00003246-199911000-00006 |
0.221 |
|
| 2004 |
DeBellis RJ, Ferro TJ, Rauch DA, Schwartz DB, Stimell ML, Volturo GA. Getting the most from antibiotic therapy - Maximizing compliance Infectious Diseases in Clinical Practice. 12: S12-S14. DOI: 10.1097/00019048-200407001-00005 |
0.218 |
|
| 2009 |
Chandran L, Gusic M, Baldwin C, Turner T, Zenni E, Lane JL, Balmer D, Bar-On M, Rauch DA, Indyk D, Gruppen LD. Evaluating the performance of medical educators: a novel analysis tool to demonstrate the quality and impact of educational activities. Academic Medicine : Journal of the Association of American Medical Colleges. 84: 58-66. PMID 19116479 DOI: 10.1097/Acm.0B013E31819045E2 |
0.213 |
|
| 2008 |
Rauch DA, Carr E, Harrington J. Inpatient brain MRI for new-onset seizures: utility and cost effectiveness. Clinical Pediatrics. 47: 457-60. PMID 18310525 DOI: 10.1177/0009922807313766 |
0.212 |
|
| 2022 |
Poondru S, Joseph A, Harding JC, Sundaramoorthi H, Mehta-Shah N, Green P, Hassan A, Rauch DA, Ratner L. Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy. Case Reports in Oncology. 15: 918-926. PMID 36636671 DOI: 10.1159/000525174 |
0.212 |
|
| 1998 |
Si ZH, Rauch D, Stoltzfus CM. The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly. Molecular and Cellular Biology. 18: 5404-13. PMID 9710624 DOI: 10.1128/Mcb.18.9.5404 |
0.209 |
|
| 2004 |
Amin A, Diamant J, Francesco LD, Feinbloom D, Ferro TJ, Holtom P, Li J, Pak M, Rauch D, Rovzar M, Seymann GB. Hospitalist Management of Community-Acquired Pneumonia: Consensus Statement Infectious Diseases in Clinical Practice. 12. DOI: 10.1097/00019048-200409002-00005 |
0.206 |
|
| 2004 |
Amin A, Diamant J, Di Francesco L, Feinbloom D, Ferro TJ, Holtom P, Li J, Pak M, Rauch D, Rovzar M, Seymann GB. Management of Community-Acquired Pneumonia Infectious Diseases in Clinical Practice. 12: S10-S16. DOI: 10.1097/01.Idc.0000139183.22587.8F |
0.203 |
|
| 2007 |
Rauch D, Zipes D. Chapter 17 – Communication and Discharge Planning Comprehensive Pediatric Hospital Medicine. 79-81. DOI: 10.1016/B978-032303004-5.50021-1 |
0.203 |
|
| 2006 |
Bass JL, Bhatia A, Boas FE, Sansary J, Rauch D. Validation of a body mass index nomogram for children as an obesity screening tool in young children. Clinical Pediatrics. 45: 718-24. PMID 16968957 DOI: 10.1177/0009922806292784 |
0.2 |
|
| 2009 |
Rauch D, Dowd D, Eldridge D, Mace S, Schears G, Yen K. Peripheral difficult venous access in children. Clinical Pediatrics. 48: 895-901. PMID 19423876 DOI: 10.1177/0009922809335737 |
0.199 |
|
| 2015 |
Borner M, Rauch D. Chimiothérapie palliative ou plutôt soins palliatifs Forum MéDical Suisse. 15: 334-339. DOI: 10.4414/Fms.2015.02225 |
0.188 |
|
| 2021 |
Peters S, Danson S, Ejedepang D, Dafni U, Hasan B, Radcliffe HS, Bustin F, Crequit J, Coate L, Guillot M, Surmont V, Rauch D, Rudzki J, O'Mahony D, Barneto Aranda I, et al. Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials. Lung Cancer (Amsterdam, Netherlands). 161: 76-85. PMID 34543941 DOI: 10.1016/j.lungcan.2021.09.002 |
0.182 |
|
| 2007 |
Gick U, Rochlitz C, Mingrone W, Pestalozzi B, Rauch D, Ballabeni P, Lanz D, Hess V, Aebi S. Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK. Oncology. 71: 54-60. PMID 17344671 DOI: 10.1159/000100449 |
0.181 |
|
| 1997 |
Rauch D, Drescher P, Knes JM, Madsen PO. Variable effects of iodinated contrast media on different rabbit arteries in vitro Urological Research. 25. PMID 9079752 DOI: 10.1007/Bf00942043 |
0.178 |
|
| 2007 |
Rauch D. Chapter 25 – Abdominal Mass Comprehensive Pediatric Hospital Medicine. 117-119. DOI: 10.1016/B978-032303004-5.50029-6 |
0.177 |
|
| 2020 |
Moccia AA, Taverna C, Schär S, Vanazzi A, Rondeau S, Hitz F, Mingrone W, Pabst T, Cevreska L, Del Giglio A, Raats J, Rauch D, Vorobiof DA, Lohri A, Ruegsegger C, et al. Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial. Blood Advances. 4: 5951-5957. PMID 33275769 DOI: 10.1182/bloodadvances.2020002858 |
0.165 |
|
| 2019 |
Burtness B, Haddad R, Dinis J, Trigo J, Yokota T, de Souza Viana L, Romanov I, Vermorken J, Bourhis J, Tahara M, Martins Segalla JG, Psyrri A, Vasilevskaya I, Nangia CS, Chaves-Conde M, ... ... Rauch D, et al. Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial. Jama Oncology. PMID 31194247 DOI: 10.1001/jamaoncol.2019.1146 |
0.164 |
|
| 2019 |
Haddad R, Guigay J, Keilholz U, Clement PM, Fayette J, de Souza Viana L, Rolland F, Cupissol D, Geoffrois L, Kornek G, Licitra L, Melichar B, Ribaldo Nicolau U, Rauch D, Zanetta-Devauges S, et al. Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial. Oral Oncology. 97: 82-91. PMID 31450171 DOI: 10.1016/j.oraloncology.2019.08.004 |
0.155 |
|
| 2018 |
Elicin O, Sermaxhaj B, Bojaxhiu B, Shelan M, Giger R, Rauch D, Aebersold DM. Incidence of second primary cancers after radiotherapy combined with platinum and/or cetuximab in head and neck cancer patients. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]. PMID 30465265 DOI: 10.1007/s00066-018-1400-5 |
0.153 |
|
| 2021 |
Deressa BT, Assefa M, Tafesse E, Kantelhardt EJ, Soldatovic I, Cihoric N, Rauch D, Jemal A. Contemporary treatment patterns and survival of cervical cancer patients in Ethiopia. Bmc Cancer. 21: 1102. PMID 34645407 DOI: 10.1186/s12885-021-08817-1 |
0.149 |
|
| 2024 |
Pokhrel NK, Panfil A, Habib H, Seeniraj S, Joseph A, Rauch D, Cox L, Sprung R, Gilmore PE, Zhang Q, Townsend RR, Yu L, Yilmaz AS, Aurora R, Park W, et al. HTLV-1 infected T cells cause bone loss via small extracellular vesicles. Biorxiv : the Preprint Server For Biology. PMID 38496506 DOI: 10.1101/2024.02.29.582779 |
0.149 |
|
| 2021 |
Rauch DA, Harding JC, Ratner L, Wickline SA, Pan H. Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma. Nanomaterials (Basel, Switzerland). 11. PMID 34208564 DOI: 10.3390/nano11061582 |
0.148 |
|
| 2021 |
Cheng X, Joseph A, Castro V, Chen-Liaw A, Skidmore Z, Payton JE, Ratner L, Edwards JR, Ueno T, Fujisawa JI, Rauch DA, Challen GA, Martinez MP, Green P, Griffith M. Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCF. Plos Pathogens. 17: e1009577. PMID 34019588 DOI: 10.1371/journal.ppat.1009577 |
0.143 |
|
| 2019 |
Deressa BT, Cihoric N, Badra EV, Tsikkinis A, Rauch D. Breast cancer care in northern Ethiopia - cross-sectional analysis. Bmc Cancer. 19: 393. PMID 31023270 DOI: 10.1186/s12885-019-5612-6 |
0.124 |
|
| 2021 |
Krugman SD, Rauch DA. The Future of Inpatient Community Hospital Care: Is There One? Hospital Pediatrics. PMID 33727366 DOI: 10.1542/hpeds.2020-003905 |
0.123 |
|
| 2018 |
Courchia B, Ramirez D, Rauch DA. Changes in Urinary Tract Infection Hospitalizations Post 2011 Revised American Academy Pediatrics Guidelines. Clinical Pediatrics. 9922818784958. PMID 29973067 DOI: 10.1177/0009922818784958 |
0.114 |
|
| 2010 |
Lye PS, Eichner JM, Chitkara MB, Melzer SM, Mirkinson LJ, Pearson-Shaver AL, Percelay JM, Rauch DA, Daru JA, Garber MD, Han YS, Hartzog TH. Clinical report - Physicians' roles in coordinating care of hospitalized children Pediatrics. 126: 829-832. PMID 20819897 DOI: 10.1542/peds.2010-1535 |
0.112 |
|
| 2022 |
Ettinger NA, Hill VL, Russ CM, Rakoczy KJ, Fallat ME, Wright TN, Choong K, Agus MSD, Hsu B, Mack E, Day S, Lowrie L, Siegel L, Srinivasan V, Gadepalli S, ... ... Rauch DA, et al. Guidance for Structuring a Pediatric Intermediate Care Unit. Pediatrics. 149. PMID 35490284 DOI: 10.1542/peds.2022-057009 |
0.109 |
|
| 2022 |
Ribi K, Pagan E, Sala I, Ruggeri M, Bianco N, Bucci EO, Graffeo R, Borner M, Giordano M, Gianni L, Rabaglio M, Freschi A, Cretella E, Seles E, Farolfi A, ... ... Rauch D, et al. Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland. Journal of Cancer Survivorship : Research and Practice. PMID 35689003 DOI: 10.1007/s11764-022-01222-y |
0.107 |
|
| 2016 |
Elicin O, Schmucking M, Bromme J, Rauch D, Ambarcioglu P, Plasswilm L, Geretschlager A, Ghadjar P, Giger R, Aebersold DM. Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis. Journal of B.U.On. : Official Journal of the Balkan Union of Oncology. 21: 175-81. PMID 27061546 |
0.106 |
|
| 2014 |
Brown C, Chitkara MB, Percelay JM, Betts JM, Jewell JA, Preuschoff CK, Rauch DA, Salerno RA, Ipsan C, Lostocco L, Vinocur CD, Scanlon M, Alexander SN. Child life services Pediatrics. 133: e1471-e1478. PMID 24777212 DOI: 10.1542/peds.2014-0556 |
0.105 |
|
| 2020 |
Mittal V, Shah N, Dwyer AC, O'Toole JK, Percelay J, Carlson D, Woods S, Lee V, Russo C, Black N, Rauch D, Chase L, Quinonez R, Fisher ES. Developing Content for Pediatric Hospital Medicine Certification Examination Using Practice Analysis. Pediatrics. PMID 32727825 DOI: 10.1542/peds.2019-3186 |
0.103 |
|
| 2020 |
Rauch D. In Reference to: "The Current State of Advanced Practice Provider Fellowships in Hospital Medicine: A Survey of Program Directors." Be Careful What We Call It. Journal of Hospital Medicine. 15: 64. PMID 31869304 DOI: 10.12788/jhm.3297 |
0.101 |
|
| 2024 |
Kisaka JK, Rauch D, Griffith M, Kyei GB. A macrophage-cell model of HIV latency reveals the unusual importance of the bromodomain axis. Virology Journal. 21: 80. PMID 38581045 DOI: 10.1186/s12985-024-02343-9 |
0.099 |
|
| 2012 |
Rauch DA, Eichner JM, Betts JM, Chitkara MB, Jewell JA, Lye PS, Mirkinson LJ, Brown C, Heiss KF, Lostocco L, Salerno RA, Percelay JM, Alexander SN, Daru JA, Garber MD, et al. Medical staff appointment and delineation of pediatric privileges in hospitals Pediatrics. 129: 782-787. DOI: 10.1542/peds.2011-3866 |
0.097 |
|
| 2012 |
Wyss E, Mueller-Garamvölgyi E, Ghadjar P, Rauch D, Zbären P, Arnold A. Diagnosis and treatment outcomes for patients with lymphoma of the parotid gland. The Laryngoscope. 123: 662-9. PMID 23203388 DOI: 10.1002/lary.23750 |
0.093 |
|
| 2023 |
Harrington Y, Rauch DA, Leary JC. Racial and Ethnic Disparities in Length of Stay for Common Pediatric Diagnoses: Trends From 2016 to 2019. Hospital Pediatrics. 13: 275-282. PMID 36911912 DOI: 10.1542/hpeds.2021-006471 |
0.091 |
|
| 2020 |
Roberts KB, Fisher ER, Rauch DA. The History of Pediatric Hospital Medicine in the United States, 1996-2019. Journal of Hospital Medicine. 15: E1-E4. PMID 32195659 DOI: 10.12788/jhm.3381 |
0.09 |
|
| 2020 |
Niro K, Gibson T, Zanger K, Rauch D, El Saleeby C. Going Virtual Amid a Pandemic: Perspectives on a Web-Based Hospital Medicine Conference. Hospital Pediatrics. PMID 33328189 DOI: 10.1542/hpeds.2020-003152 |
0.087 |
|
| 2022 |
Schroeder AR, Solan LG, Williams D, Thomas B, Smith C, Minshew G, Rauch DA. Reviewer feedback for abstract submissions to the Pediatric Academic Societies meeting: a pilot project. Academic Pediatrics. PMID 35318158 DOI: 10.1016/j.acap.2022.02.018 |
0.063 |
|
| 2021 |
Cushing AM, Bucholz EM, Chien AT, Rauch DA, Michelson KA. Availability of Pediatric Inpatient Services in the United States. Pediatrics. PMID 34127553 DOI: 10.1542/peds.2020-041723 |
0.057 |
|
| 2010 |
Rauch DA, Nale RD, Wathen SA, Barr PB. An application of importance-performance analysis to university marketing International Journal of Electronic Marketing and Retailing. 3: 55-65. DOI: 10.1504/IJEMR.2010.030507 |
0.056 |
|
| 1997 |
Rauch DA, Romano P. Hemorrhagic ovarian cysts Emergency and Office Pediatrics. 10: 20-23. |
0.045 |
|
| 2004 |
Reubi JC, Koefoed P, Hansen Tv, Stauffer E, Rauch D, Nielsen FC, Rehfeld JF. Procholecystokinin as marker of human Ewing sarcomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 5523-30. PMID 15328192 DOI: 10.1158/1078-0432.CCR-1015-03 |
0.033 |
|
| 2023 |
Rauch DA, Victoria T, Pfeifer HH. Case 25-2023: An 18-Year-Old Man with Fever and Foot Pain. The New England Journal of Medicine. 389: 643-651. PMID 37585631 DOI: 10.1056/NEJMcpc2211358 |
0.032 |
|
| 1998 |
Rauch DA. Experience and reason - Briefly recorded Pediatrics. 102: 404-405. DOI: 10.1542/peds.102.2.404 |
0.029 |
|
| 1995 |
Rauch DA. A 15-year-old female with seizure-like activity Emergency and Office Pediatrics. 8: 54-56. |
0.025 |
|
| 2009 |
Chandran L, Gusic M, Baldwin C, Turner T, Zenni E, Lane JL, Balmer D, Bar-on M, Rauch D, Indyk D. APA Educator Portfolio Analysis Tool Mededportal. 5. DOI: 10.15766/mep_2374-8265.1659 |
0.023 |
|
| 2023 |
Rauch D. Teaching Scholarship and Who Needs to Learn It. Hospital Pediatrics. PMID 38073336 DOI: 10.1542/hpeds.2023-007534 |
0.02 |
|
| 2015 |
Rauch DA, Collins MD, Nale RD, Barr PB. Measuring service quality in mid-scale hotels International Journal of Contemporary Hospitality Management. 27: 87-106. DOI: 10.1108/IJCHM-06-2013-0254 |
0.018 |
|
| 2004 |
Mulè F, Rauch D, Moore RS, Nield LS, Moore CA, Byerley J, Basinger A, Lau E, White A. Index of suspicion. Pediatrics in Review / American Academy of Pediatrics. 25: 254-9. PMID 15231992 |
0.01 |
|
| Hide low-probability matches. |